Patents by Inventor Elena Fingerut

Elena Fingerut has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8168750
    Abstract: A nucleic acid sequence encoding a fragment of the adenovirus fiber capsid protein, a DNA construct including a replicable expression vector and at least one heterologous nucleic acid, and recombinant protein including fragment of the adenovirus fiber capsid protein. The fragment comprises the C-terminal knob and part of the shaft domain of the fiber protein of these adenoviruses. The use of recombinant proteins as an active ingredient in vaccinating compositions for conferring to an animal immunity against a pathogenic infection by an adenovirus, and methods for vaccinating a domestic bird against a pathogenic adenoviral infection.
    Type: Grant
    Filed: December 6, 2010
    Date of Patent: May 1, 2012
    Assignee: ABIC Biological Laboratories Ltd.
    Inventors: Jacob Pitcovski, Elena Fingerut, Bezalel Gutter, Gilad Gallili, Amnon Michael
  • Publication number: 20110159024
    Abstract: A nucleic acid sequence encoding a fragment of the adenovirus fiber capsid protein, a DNA construct including a replicable expression vector and at least one heterologous nucleic acid, and recombinant protein including fragment of the adenovirus fiber capsid protein. The fragment comprises the C-terminal knob and part of the shaft domain of the fiber protein of these adenoviruses. The use of recombinant proteins as an active ingredient in vaccinating compositions for conferring to an animal immunity against a pathogenic infection by an adenovirus, and methods for vaccinating a domestic bird against a pathogenic adenoviral infection.
    Type: Application
    Filed: December 6, 2010
    Publication date: June 30, 2011
    Inventors: Jacob Pitcovski, Elena Fingerut, Bezalel Gutter, Gilad Gallili, Amnon Michael
  • Patent number: 7858766
    Abstract: A nucleic acid sequence encoding a fragment of the adenovirus fiber capsid protein, a DNA construct including a replicable expression vector and at least one heterologous nucleic acid, and recombinant protein including fragment of the adenovirus fiber cpasid protein. The fragment comprises the C-terminal knob and part of the shaft domain of the fiber protein of these adenoviruses. The use of recombinant proteins as an active ingredient in vaccinating compositions for conferring to an animal immunity against a pathogenic infection by an adenovirus, and methods for vaccinating a domestic bird against a pathogenic adenoviral infection.
    Type: Grant
    Filed: March 4, 2003
    Date of Patent: December 28, 2010
    Assignee: Abic Biological Laboratories Teva Ltd.
    Inventors: Jacob Pitcovski, Elena Fingerut, Bezalel Gutter, Gilad Gallili, Amnon Michael
  • Publication number: 20090304733
    Abstract: The present invention provides a recombinant toxin or the subunit B thereof selected from the group consisting of E. coli heat-labile enterotoxin (LT), its subunit B (LTB), cholera toxin (CT) and its subunit B (CTB), in immunogenic form, expressed in eukaryotic cells, a vaccine comprising said toxin or subunit B thereof, and use of said recombinant toxin or subunit B thereof in human or veterinary vaccines.
    Type: Application
    Filed: July 28, 2005
    Publication date: December 10, 2009
    Inventors: Jacob Pitcovski, Yelena Vasserman, Elena Fingerut
  • Publication number: 20070053935
    Abstract: The present invention relates to a nucleic acid sequence encoding a fragment of the adenovirus fiber capsid protein, particularly, of the avian adenoviruses HEV or EDS. This sequence comprises the C-terminal knob and part of the shaft domain of the fiber protein of these adenoviruses. The invention further provides for DNA constructs comprising said DNA fragment and recombinant proteins encoded thereby. The recombinant proteins of the invention elicit in an animal, preferably in a domestic bird, protective immunity against a specific viral pathogen. The invention further relates to the use of these recombinant proteins as an active ingredient in vaccinating compositions for conferring to an animal immunity against a pathogenic infection by an adenovirus, and to methods for vaccinating a domestic bird against a pathogenic adenoviral infection.
    Type: Application
    Filed: March 4, 2003
    Publication date: March 8, 2007
    Inventors: Jacob Pitcovski, Elena Fingerut, Bezalel Gutter, Gilad Gallili, Amnon Michael